HighPoint Blog

Co-authored by Suzanne Kunze, RN, CCM, MBA and John Miller

Read More

The latest pricing structure shift from Medicaid won’t be the destruction of the generic industry. But drug manufacturers will be impacted and need to take steps to comply with the proposed regulation.

Read More

Recent Posts